FLT3 Mutation Increases Relapse Risk after Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia in First or Second Complete Remission: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

被引：0

作者：

Deol, Abhinav ^{[1
]}

Sengsayadeth, Salyka ^{[2
]}

Jagasia, Madan ^{[2
]}

Ahn, Kwang W. ^{[3
]}

Wang, Hailin ^{[4
]}

Sandmaier, Brenda M. ^{[5
]}

Devine, Steven M. ^{[6
]}

de Lima, Marcos ^{[7
]}

Weisdorf, Daniel J. ^{[8
]}

Saber, Wael ^{[9
]}

机构：

[1] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI USA

[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[3] Med Coll Wisconson, CIBMTR, Milwaukee, WI USA

[4] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[5] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

[6] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[7] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA

[8] Univ Minnesota, Minneapolis, MN USA

[9] Med Coll Wisconsin, CIBMTR, Milwaukee, WI 53226 USA

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[41] Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
Antonio M. Jimenez Jimenez
Marcos De Lima
Krishna V. Komanduri
Trent P. Wang
Mei-Jie Zhang
Karen Chen
Hisham Abdel-Azim
Muhammad Bilal Abid
Mahmoud Aljurf
Hassan Alkhateeb
Amer Assal
Ulrike Bacher
Frédéric Baron
Minoo Battiwalla
Amer Beitinjaneh
Nelli Bejanyan
Vijaya Raj Bhatt
Michael Byrne
Jean-Yves Cahn
Mitchell Cairo
Paul Castillo
Edward Copelan
Zachariah DeFilipp
Miguel Angel Diaz Perez
Mahmoud Elsawy
Robert Peter Gale
Biju George
Michael R. Grunwald
Gerhard C. Hildebrandt
William J. Hogan
Christopher G. Kanakry
Ankit Kansagra
Mohamed A. Kharfan-Dabaja
Nandita Khera
Maxwell M. Krem
Aleksandr Lazaryan
Joseph Maakaron
Rodrigo Martino
Joseph McGuirk
Fotios V. Michelis
Giuseppe Milone
Asmita Mishra
Hemant S. Murthy
Alberto Mussetti
Sunita Nathan
Taiga Nishihori
Richard F. Olsson
Neil Palmisiano
Sagar Patel
Ayman Saad
Bone Marrow Transplantation, 2022, 57 : 852 - 852
[42] Impact of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) on the Outcomes of Angioimmunoblastic T-Cell Lymphoma (AITL): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis
Epperla, Narendranath
Ahn, Kwang Woo
Litovich, Carlos
Kharfan-Dabaja, Mohamed A.
Smith, Sonali M.
Sureda, Anna
Fenske, Timothy S.
Hamadani, Mehdi
BLOOD, 2018, 132
[43] FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation
G Yoshimoto
K Nagafuji
T Miyamoto
N Kinukawa
K Takase
T Eto
K Kato
S Hayashi
T Kamimura
Y Ohno
S Taniguchi
M Harada
Bone Marrow Transplantation, 2005, 36 : 977 - 983
[44] FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation
Yoshimoto, G
Nagafuji, K
Miyamoto, T
Kinukawa, N
Takase, K
Eto, T
Kato, K
Hayashi, S
Kamimura, T
Ohno, Y
Taniguchi, S
Harada, M
BONE MARROW TRANSPLANTATION, 2005, 36 (11) : 977 - 983
[45] Improved FLT3 Internal Tandem Duplication PCR Assay Predicts Outcome after Allogeneic Transplant for Acute Myeloid Leukemia
Grunwald, Michael R.
Tseng, Li-Hui
Lin, Ming-Tseh
Pratz, Keith W.
Eshleman, James R.
Levis, Mark J.
Gocke, Christopher D.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (12) : 1989 - 1995
[46] Excellent Overall Survival and Low Incidence of Late Effects in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Sickle Cell Disease: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR)
Stenger, Elizabeth
Phelan, Rachel
Shaw, Bronwen E.
Battiwalla, Minoo
Bo-Subait, Stephanie
Brazauskas, Ruta
Buchbinder, David K.
Hamilton, Betty K.
Shenoy, Shalini
Krishnamurti, Lakshmanan
BLOOD, 2019, 134
[47] Impact of Allogeneic Hematopoietic Cell Transplantation in First Complete Remission in Addition to FLT3 Inhibition with Quizartinib in Acute Myeloid Leukemia with FLT3-Internal Tandem Duplication: Results from the Quantum-First Trial
Schlenk, Richard F.
Montesinos, Pau
Romero-Aguilar, Antonio
Vrhovac, Radovan
Patkowska, Elzbieta
Kim, Hee-Je
Zak, Pavel
Wang, Po-Nan
Hanyok, James
Liu, Li
Kamel, Yasser Mostafa
Benzohra, Aziz
Lesegretain, Arnaud
Cortes, Jorge E.
Sekeres, Mikkael A.
Dombret, Herve
Amadori, Sergio
Wang, Jianxiang
Perl, Alexander E.
Levis, Mark J.
Erba, Harry P.
BLOOD, 2022, 140 : 2130 - 2132
[48] Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission
Michelis, F. V.
Atenafu, E. G.
Gupta, V.
Kim, D. D.
Kuruvilla, J.
Lipton, J. H.
Loach, D.
Seftel, M. D.
Uhm, J.
Alam, N.
Lambie, A.
McGillis, L.
Messner, H. A.
BONE MARROW TRANSPLANTATION, 2015, 50 (07) : 907 - 913
[49] Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission
F V Michelis
E G Atenafu
V Gupta
D D Kim
J Kuruvilla
J H Lipton
D Loach
M D Seftel
J Uhm
N Alam
A Lambie
L McGillis
H A Messner
Bone Marrow Transplantation, 2015, 50 : 907 - 913
[50] ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT CAN AMELIORATE THE ADVERSE IMPACT OF FLT3-ITD MUTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH NORMAL CYTOGENETICS
Loh, Y.
How, G. F.
Hwang, W.
Linn, Y. C.
Goh, Y. T.
Diong, C. P.
Lim, L. C.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 652 - 653

← 1 2 3 4 5 →